Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EVARREST vs SoC for Bleeding in Hepatic Surgery
NCT01993888Phase 3Completed
- Sponsor
- Ethicon
- Start
- Oct 2013
- Primary completion
- Jul 2014
- Modality
- Recombinant Proteins and Enzymes, Device-based Delivery
- Countries
- 4
01
Overview
Phase 3, randomised, open-label trial in hemorrhage comparing EVARREST with Standard of Care (2 arms). Primary endpoint: Hemostasis at the Target Bleeding Site (TBS) at 4-minutes Following Randomization. Started Oct 2013; status: completed.
02
Drugs
Fibrin Pad
03
Conditions
hemorrhage
Beyond the preview
Go deeper on NCT01993888.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01993888.